MCM COVID-19 Presentation: Roadmap to a COVID-19 Vaccine: Clinical Considerations for Ensuring Safety and Efficacy Part 1

MCM COVID-19 Presentation: Roadmap to a COVID-19 Vaccine: Clinical Considerations for Ensuring Safety and Efficacy Part 1Vaccine Clinical Trial Design and Vaccine Development During a Pandemic

 

In this presentation from the 2020 Midyear Clinical Meeting, content matter experts describe clinical trial designs for COVID-19 vaccine candidates, identify important documentation requirements and safety surveillance measures and actions, outline opportunities to address vaccine hesitancy, calculate the number needed to vaccinate to stop widespread community transmission of SARS CoV-2 and discuss clinical implications related to COVID-19 vaccine(s) made available through Emergency Use Authorization.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.